SCI Abstract

search
Utilization of Apixaban Pharmacokinetics for Dose Optimization in High-Risk Elderly Patients
Utilization of Apixaban Pharmacokinetics for Dose Optimization in High-Risk Elderly Patients
Direct oral anticoagulants have largely replaced vitamin K antagonists, for example, warfarin, because of their favorable ...
Predicting Cumulative Neonatal Sodium Benzoate Exposures During Breastfeeding with Physiologically Based Pharmacokinetic Modelling
Predicting Cumulative Neonatal Sodium Benzoate Exposures During Breastfeeding with Physiologically Based Pharmacokinetic Modelling
Sodium benzoate (SB) is used as a second-line therapy to treat rare urea cycle disorders (UCDs) in paediatric and adult pa...
Model-Informed Precision Dosing of Protein Kinase Inhibitors: Evaluation of Model-Averaging and Flattened Priors Methods
Model-Informed Precision Dosing of Protein Kinase Inhibitors: Evaluation of Model-Averaging and Flattened Priors Methods
Therapeutic drug monitoring of protein kinase inhibitors (PKIs) usually relies on the measure of a single trough concentra...
Pharmacokinetics of Asciminib 200 mg in the Presence of a Strong CYP3A4 Inducer, Phenytoin, in Healthy Participants
Pharmacokinetics of Asciminib 200 mg in the Presence of a Strong CYP3A4 Inducer, Phenytoin, in Healthy Participants
Asciminib is indicated for the treatment of adult patients with newly diagnosed or previously treated Philadelphia chromos...
Single Saliva Sample Linezolid Dosing for Multidrug-Resistant Tuberculosis: A Population Pharmacokinetic Modelling of Plasma and Saliva
Single Saliva Sample Linezolid Dosing for Multidrug-Resistant Tuberculosis: A Population Pharmacokinetic Modelling of Plasma and Saliva
Therapeutic drug monitoring (TDM) of linezolid for treating multidrug-resistant tuberculosis (MDR-TB) is recommended but i...
Optimising Paediatric Medication Adherence Through Innovative Drug Formulations and Delivery Systems
Optimising Paediatric Medication Adherence Through Innovative Drug Formulations and Delivery Systems
Medication adherence remains a significant challenge in healthcare, particularly in paediatric populations, where non-adhe...
Exposure-Response Relationships of Antibody Drug Conjugates in Solid Tumours
Exposure-Response Relationships of Antibody Drug Conjugates in Solid Tumours
Over the last decade, there has been an increase in development of antibody drug conjugates (ADCs), a drug class designed ...
Why the Assay Matters in Model-Informed Precision Dosing: An Example of Ustekinumab in Crohn’s Disease
Why the Assay Matters in Model-Informed Precision Dosing: An Example of Ustekinumab in Crohn’s Disease
Systematic bias between therapeutic drug monitoring assays may lead to inappropriate treatment decisions in clinical pract...
Evaluating Bayesian Vancomycin Dosage Adjustment in Neonates: A Simulation-Based Virtual TDM Study
Evaluating Bayesian Vancomycin Dosage Adjustment in Neonates: A Simulation-Based Virtual TDM Study
Therapeutic drug monitoring (TDM) of vancomycin, ideally based on the ratio of the daily area under the curve to the minim...
Effect of Enzalutamide on Morphine Exposure in Patients with Prostate Cancer
Effect of Enzalutamide on Morphine Exposure in Patients with Prostate Cancer
Pain management in patients with prostate cancer receiving enzalutamide is challenging owing to its high potential for dru...
Precision Dosing of Vancomycin: A Systematic Review of Population Pharmacokinetics Models and Comparative Evaluation of Software Tools
Precision Dosing of Vancomycin: A Systematic Review of Population Pharmacokinetics Models and Comparative Evaluation of Software Tools
Vancomycin is a widely used antibiotic with a narrow therapeutic window and considerable pharmacokinetic variability, nece...
Population Pharmacokinetic/Pharmacodynamic Modeling of Therapeutic Enzymes in Lysosomal Storage Diseases
Population Pharmacokinetic/Pharmacodynamic Modeling of Therapeutic Enzymes in Lysosomal Storage Diseases
Lysosomal storage diseases (LSDs) are rare genetic disorders treated with enzyme replacement therapy (ERT). However, treat...
Malnutrition and Its Effect on Drug Pharmacokinetics: A Clinical Perspective
Malnutrition and Its Effect on Drug Pharmacokinetics: A Clinical Perspective
Malnutrition significantly alters the pharmacokinetics of medications, particularly in vulnerable populations such as chil...
Double Peaking Phenomena in Pharmacokinetic Disposition Revisited
Double Peaking Phenomena in Pharmacokinetic Disposition Revisited
Multiple peaking in pharmacokinetics refers to the occurrence of two or more peaks of drug plasma concentrations following...
Clinical Pharmacology Profile of the Claudin 18.2 Antibody Zolbetuximab
Clinical Pharmacology Profile of the Claudin 18.2 Antibody Zolbetuximab
Zolbetuximab is a first-in-class chimeric (mouse/human) monoclonal antibody targeted to the tight junction protein claudin...
Immunoglobulin G Receptors (FcγR), in Addition to Target-Antigen and Neonatal Fc Receptor (FcRn), Influence Rituximab Pharmacokinetics
Immunoglobulin G Receptors (FcγR), in Addition to Target-Antigen and Neonatal Fc Receptor (FcRn), Influence Rituximab Pharmacokinetics
Rituximab, an anti-cluster of differentiation (CD)-20 monoclonal antibody, is used in the treatment of non-Hodgkin lymphom...